PROGEN — Prostatype Genomics AB Share News
0.000.00%
Last trade - 00:00- SEK52.52m
- SEK52.13m
- SEK0.59m
Brief: Prostatype Genomics Submits Medicare Reimbursement Application In U.S. Market For Gene Test Prostatype
Brief: Prostatype Genomic's Bod Proposes Reverse Share Split
Brief: Prostatype Genomics Decides On Directed Issue To Guarantors
Brief: Prostatype Genomics Rights Issue Closes with 79.8% Subscription
Brief: Prostatype Publishes Update On Commercial Progress In Spain
Brief: Prostatype Genomics Carries Out Rights Issue Of Units Of SEK 49.5 Mln
Brief: Anders Lundberg Is Elected Chairman Of Prostatype Genomics
Brief: Prostatype Genomics Updates On Progress With Prostatype Study
Brief: Prostatype Genomics Announces Strong Positive Final Results From Multicentre Study With Prostatype In Spain
Brief: Prostatype Genomics H2 EBITDA Loss Widens To SEK 17.8 Mln
Brief: Prostatype Genomics Gets CAP Laboratory Accreditation
Brief: Prostatype Genomics Acquires Clia Certificate
Brief: Prostatype Genomics, Researchdx In CLIA-Laboratory Agreement For US Market
Brief: Prostatype Genomics Carries Out Directed Share Issue
Brief: Prostatype Genomics Announces Preliminary Outcome Of Rights Issue
Brief: Prostatype Genomics Says Net Sales For Q3 Amounted To Approx 530 Tsek, Compared To 109 Tsek For Same Period Last Year
Brief: Prostatype Genomics Informs About Market Capitalization Value On Certain Financial Websites
Brief: Prostatype Genomics Resolves On Rights Issue Of About SEK 47.8 Mln
Brief: Prostatype Genomics Gets First Order Of Prostatype® In Switzerland